Contraception Flashcards

1
Q

Rhythm method

A
  • increase in basal temp means ovulation has occured
  • abstenence for 5-10 d around ovulation
  • Track mucus: abundant, thin, wand watery
  • Measure for LH levels in urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Is a Gyneclogical exam recommended before CHC prescription given?

A

No, but Med history and BP measurement needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is ovulation inhibited?

A

Progestins block LH surge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which progestin is available as a contraceptive patch?

A

Norelgestromin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Other effects of progestins

A

Thicken cervical mucus, induce endometrial atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most common Estrogen in CHCs?

Dose?

A
Ethinyl Estradiol (EE)
20-25 ug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Estrogens function in CHC

A
  • Suppress FSH, prevent LH surge

- Stabilize endometrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which hormone provides most of the effect in CHC?

A
the progestins
Mimics pregnancy (Corpus luteum secretes progesterone to prevent 2nd ovulation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Non-contraceptive benefits of CHC`

A
  • Decreased menstrual problems (cramps, pain, irregularity), Acne
  • Decreased risk of ovarian andometriial cancers, ovarian cysts, Pelvic inflammatory disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CHC ADRs; Estrogen excess

A
  • Nausea, breast tenderness, HA, Fluid Retention**

- Treat by decreasing estrogen dose, using progestin only, or IUD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CHC ADRs; Estrogen deficiency

A
  • Midcycle breakthrough bleeding
  • Vasomotor symptoms (hot flashes), anxiety, decreased libido
  • Amenorrhea
  • Treated by increasing estrogen dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CHC ADRs; Progestin Excess

A
  • Increased appetite, weight gain, bloating
  • Acne, oily skin, hirsutisim
  • Depression, fatigue, irritability
  • Treat by decreasing progestin dose or use less androgenic progestin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CHC ADRs; Progestin deficiency

A
  • Dysmenorrhea, late cycle breakthrough bleeding/spotting

- Treat by increasing progestin dose, use extended cycle or continuous regimen, or progestin-only, or IUD contraception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CHC risks and age

A

low dose (

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CHC and smokers

A

Women over 35 and smokers are advised against COCs

-Progestin-only methods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Use of CHC in perimenopausal women

A

Helps increase bone mineral density and helps with vaso motor symptoms (hot flashes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

CHCs and HTN

A
  • Even low dose EE increases BP

- Use ok in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CHC and Dyslipidemias

A

-Progestins decrease HDL; increase LDL
-Estrogens decrease LDL; increase HDL
–>CHC usually no effect lipid profile
–>if controlled, can use CHC
Else (LDL>160 mg/dL) no use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is theCVD risk with CHCs in dyslipidemia

A

Thrombosis, not atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Diabetes and CHCs

A

In healthy pt:
Most have no affect on insulin or HbA1c
Noincreased risk of TIIDM
**Women with DM should not use CHCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CHCs and migraines

A

CHCs increase and decrease risk of migraines

  • Prodromal aura –> stroke risk
  • *Women subject to migraines should not use CHCs
  • *If migraines develop, D/c immediately

***Progestin only may be substituted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CHCs and Breast Cancer

A

No association

OK in benign breast disease, and family history of BC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

CHCs and thromboembolism

A

Estrogens increase hepatic production of clotting factors

  • -> risk of DVT & PE
  • -> Less risk than occurs in pregnancy, but still risk

**contraindicated in women with Hx of thromboembolic events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which CHC has least risk of thromboembolic event

A

Levonorgestrel less than desorgestrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
CHCs and obesity risks
- Obese pt increased risk for contraceptive failure | - Increased risk of VTE
26
CHCs and obesity | Preferred therapy
Depot MPA or Levonorgestrel IUD preffered
27
CHCs and Lupus
should be avoided in pt with SLE + anti-phospholipid antibodies or vascular complications **Use progestin only contraceptives
28
Which progestin has anti-aldosterone effects? | What is that effect
Drospirenone | Less bloating/weight gain
29
3rd/4th gen progestins
Dropirenone, Deogestrel, norgestimate
30
What warning must be on Drospirenone (Yasmin, Yaz, Beyaz, Safyral) box?
Increased risk of VTE
31
Progestin only pills
-Less effective -irregular bleeding -Must be taken at same time every day 40% of women still ovulate
32
COC first line
low dose
33
COC choice for adolescents, underweight, women over 35, perimenopausal
Very low dose. 20-25 ug EE
34
COC choice for women >160 lbs
35-50 ug EE. Do not exceed 50 ug
35
Progestin-only candidates
-Migraines with aura -Thromboembolic diseases -SLE -Women >35 y with: +smoker +obseity +HTN
36
``` Transdermal patch (Ortho Evra) Contents ```
Ethinyl Estradiol + norelgestromin
37
Transderm effectivenes
Equally effective as COCs, but higher failure rate in women >189 lbs
38
Transdermal EE exposure
- 60% higher: avoids first pass metabolism | - possible thromboembolic risk
39
``` Vaginal rings (Nuvaring) Contents ```
EE + Etonogestrel
40
Vaginal rings effectiveness
Equally effective as COCs | Lower systemic dose of estrogen
41
Vaginal rings use
Inserted and worn for 3 weeks
42
Depo-Provera (injectable progestin) | Dose/drug/route(s)
150 mg medroxyprogesteron acetate (DMPA) IM (also SC)
43
Depo-provera | duration *efficacy
3 months, 97% actual efficacy
44
Depo cessation
prolonged delay to fertility (10-18 months)
45
Depo risk
DMPA suppresses estradiol production, risk of decreased bone mineral density
46
Implanton sub dermal progestin implant | Drug, duration, effectiveness
etonorgestrel 3 years 97%
47
Implanon complaints
irregular menstrual bleeding and spotting
48
Implanon and BMD
No decrease in BMD
49
Implanon and removal
rapid return to fertility
50
Intra uteron deices Types MOA
``` Copper ions (paragard) or levonorgestrel (Mirena, skyla, liletta) Reduce sperm mobility or interfere with implantation ```
51
Intra uterine device effectiveness
99&
52
Paragaurd Duration ADRs
10 years Increase blood flow by 35% Increased dysmenorrhea
53
Mirena Duration dose
5 years10 | ug pregestin/d with low systemic absorption
54
Mirena ADRs
reduces menstrual blood flow but increases spotting in first year. Amenorrhea 20% first year 60% fifth
55
IUDs general ADR | and removal
- May increase pelvic inflammatory disease | - Fertility returns immediately after
56
What is the most widely used reversible contraception?
IUD
57
``` Emergency Contraception (Plan B) Contents ```
1.5 mg levonorgestrel | Taken 1 dose or two split doses q12h
58
Plan B MOA
Prevent ovulation, sperm motility | DO NOT EFFECT IMPLANTATION (if ovulation has already occurred: you're screwed
59
Plan B use
should be taken within 72 h of intercourse (max 5d)
60
Plan B adverse effects
Nausea | May induce withdrawal bleeding
61
Plan be availability
Available behind the counter to patients of lll ages
62
Yuzpe regimen
COCs for emergency contraception | 100 ug EE + 0.5 mg levonorgestrel; repeate after 12 h
63
Anti-progestins | Eg,
Ulipristal (ella) | Mifepristone
64
Anti-progestin | MOA
- Block ovulation, impare endometrial proliferation - Effective up until day of LH surge - Longer acting than levonorgestrel
65
Anti-progestins use by
Must be within 5 days of coitus
66
Which EC is considered embrotoxic?
Anti-progestins
67
Anti-progestin availability
Rx Only
68
Anti-progestin contraindications and ADRs
- Metabolized by CYP3A4 - Contraindicated in severe liver disease - Minimal ADR: abdominal pain
69
Copper IUD (paragaurd) EC Use by Effectiveness
up to 5 d post coitus | most effective EC 99%